Weight loss drugs 1 factor behind ACA premium increases: 3 things to know
(By Rylee Wilson for Becker’s Hospital Review) Premiums for plans on the ACA marketplace will rise 7% on average in
Read More
Wegovy
Costly GLP-1 Drugs are Rarely Covered for Weight Loss by Marketplace Plans
(By Tammie Smith for The Kaiser Family Foundation published June 12, 2024) Affordable Care Act (ACA) Marketplace plans rarely cover
Read MorePoll: 1 in 8 Adults Say They’ve Taken a GLP-1 Drug, Including 4 in 10 of Those with Diabetes and 1 in 4 of Those with Heart Disease
(By Tammie Smith at The Kaiser Family Foundation published May 10, 2024) About one in eight adults (12%) say they
Read MoreAn Estimated 1 in 4 Medicare Beneficiaries With Obesity or Overweight Could Be Eligible for Medicare Coverage of Wegovy, an Anti-Obesity Drug, to Reduce Heart Risk
(By Chris Lee for The Kaiser Family Foundation published April 24, 2024) In a new analysis, KFF finds that 3.6
Read MoreA New Use for Wegovy Opens the Door to Medicare Coverage for Millions of People with Obesity
(By Juliette Cubanski, Tricia Neuman, Nolan Sroczynski, and Anthony Damico for The Kaiser Family Foundation Published: Apr 24, 2024) The
Read More